Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for DHR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 26.56B
March 31, 2026 18.48B
December 31, 2025 19.50B
September 30, 2025 16.86B
June 30, 2025 17.36B
March 31, 2025 16.48B
December 31, 2024 16.97B
September 30, 2024 17.52B
June 30, 2024 17.01B
March 31, 2024 18.16B
December 31, 2023 19.36B
September 30, 2023 22.06B
June 30, 2023 19.88B
March 31, 2023 19.83B
December 31, 2022 20.45B
September 30, 2022 19.25B
June 30, 2022 20.06B
March 31, 2022 21.78B
December 31, 2021 23.06B
September 30, 2021 23.60B
June 30, 2021 20.42B
March 31, 2021 20.28B
December 31, 2020 21.99B
September 30, 2020 21.83B
June 30, 2020 22.39B
Date Value
March 31, 2020 25.97B
December 31, 2019 22.37B
September 30, 2019 18.42B
June 30, 2019 11.08B
March 31, 2019 10.29B
December 31, 2018 9.740B
September 30, 2018 10.62B
June 30, 2018 11.32B
March 31, 2018 10.51B
December 31, 2017 10.52B
September 30, 2017 10.91B
June 30, 2017 11.59B
March 31, 2017 11.95B
December 31, 2016 12.27B
September 30, 2016 8.312B
June 30, 2016 14.65B
March 31, 2016 12.39B
December 31, 2015 12.87B
September 30, 2015 15.01B
June 30, 2015 3.163B
March 31, 2015 3.178B
December 31, 2014 3.473B
September 30, 2014 3.036B
June 30, 2014 3.069B
March 31, 2014 3.487B

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 3.645B
Thermo Fisher Scientific, Inc. 42.55B
Illumina, Inc. 2.445B
Waters Corp. 5.403B
Bio-Rad Laboratories, Inc. 1.337B